NCT04640623 · Interventional trial
A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy
Overall registry status Active not recruiting
Phase 2
Conditions Urinary Bladder Neoplasms
Delaware Valley sites
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County
- Urologic Consultants of Southeastern Pennsylvania · Bala-Cynwyd, PA · Montgomery County
First posted
Registry updated
Added to the directory